Outcomes of Treatment for Methamphetamine Use: LA County (“Treatment-as-Usual”) M.-L. Brecht UCLA Integrated Substance Abuse Programs CATES 3/30/2004.

Slides:



Advertisements
Similar presentations
Etienne Maffli Swiss Institute for the Prevention of Alcohol and other Drug Problems Lausanne, Switzerland Characteristics of male and female outpatients.
Advertisements

Amity In-Prison Therapeutic Community: Preliminary Five-Year Outcomes
13 Principles of Effective Addictions Treatment
XR-NTX Implementation in Los Angeles County Desirée A. Crèvecoeur-MacPhail, PhD UCLA Integrated Substance Abuse Programs Santa Monica Blvd., Suite.
1 Intervening in the Recovery Process Michael L. Dennis, Ph.D. Christy K Scott, Ph.D. Chestnut Health Systems, Bloomington &Chicago, IL U.S.A. Presentation.
Gender Differences in Health Status Among Opiate Users in a 25-Year Follow-up Study Christine Grella & Luz Rodriguez UCLA Integrated Substance Abuse Programs.
Predictors of Change in HIV Risk Factors for Adolescents Admitted to Substance Abuse Treatment Passetti, L. L., Garner, B. R., Funk, R., Godley, S. H.,
Background: The low retention rates among African Americans in substance abuse treatment (Milligan et al., 2004) combined with the limited number of treatments.
Differences in Characteristics of Heroin Inhalers and Injectors at Admission to Treatment J. C. Maxwell, R. T. Spence, & T. M. Bohman UT Center for Social.
Preliminary Findings: Recovery Center Outcome Study
C. Andres Bedoya, PhD Behavioral Medicine Service Department of Psychiatry Massachusetts General Hospital / Harvard Medical School Factors related to high-risk.
Trajectories of criminal behavior among adolescent substance users during treatment and thirty-month follow-up Ya-Fen Chan, Ph.D., Rod Funk, B.S., & Michael.
Jane Ungemack, DrPH University of Connecticut Health Center Governor’s Prevention Initiative for Youth Evaluation Team Needs Assessment Training Session.
The costs and effectiveness of substance abuse treatment programs for pregnant women Marilyn Daley, Ph.D. Conference on Harm Reduction Strategies in Uzbekistan.
Motivational Interviewing to Improve Treatment Engagement and Outcome* The effect of one session on retention Research findings from the NIDA Clinical.
Challenges and Successes Treating Adolescent Substance Use Disorders Janet L. Brody, Ph.D. Center for Family and Adolescent Research (CFAR), Oregon Research.
 It is when one is dependent on any kind of substance, illegal drug or a medication  You may not be able to control your drug use  It can cause an.
UCLA Drug Abuse Research CenterForever Free Evaluation Forever Free Substance Abuse Treatment Program Outcomes Study Michael Prendergast, Ph.D., Principal.
Research Strategies to Test Behavioral/Psychotherapy Treatments for Substance Use Disorders: Several Examples Richard A. Rawson, Ph.D UCLA ISAP Cairo,
Does Case Management Improve Linkage to Substance Abuse Treatment? By Erin.
SUBSTANCE USE DISORDERS GENERAL METHODS OF TREATMENT Inpatient Detoxification and Rehabilitation Outpatient Individual, Couple, or Family Counseling Self-help.
Factors that Influence Retention in Greek Therapeutic Communities Erianna Daliani MSc (Gerasimos Papanastasatos) KETHEA Research Dept. 11th European Conference.
Audrey J. Brooks, PhD University of Arizona CA-AZ node.
Using Research/Evaluation Questions to Define Data Collection and Findings: Findings from the FY 2004 KTOS Follow-up Study Robert Walker, Allison Mateyoke-Scrivener,
CHAPTER 1- INTRODUCTION AND PRIMARY PREVENTION Psychology 63- Alcohol/ Drug Studies- Prevention and Education.
ILLINOIS STATEWIDE TREATMENT OUTCOMES PROJECT. Illinois Statewide Treatment Outcomes Project Largest evaluation of treatment outcomes by the State to.
C:\laam\lamAPA.ppt 8/04/98 Heroin Addiction Treatment: A Comparison of Methadone and LAAM M. Douglas Anglin, Ph.D. Douglas Longshore, Ph.D. Jeffrey J.
Results of the Vivitrol Pilot in Los Angeles County Presented by: Desiree A. Crevecoeur-MacPhail, Ph.D. Research Psychologist, UCLA ISAP.
METHODS Sample n=245 Women, 24% White, 72% Average age, 36.5 Never married, 51% Referral Sources (%) 12-Month DSM-IV Substance Dependence Prior to Entering.
EFFECTIVE INTERVENTIONS FOR NEWBORNS WITH DRUG EXPOSURE AND THEIR FAMILIES Harolyn M.E. Belcher, M.D., M.H.S. Associate Professor of Pediatrics Johns Hopkins.
UCLA’s Statewide Evaluation of Proposition 36 Darren Urada, Ph.D. UCLA Integrated Substance Abuse Programs Association for Criminal Justice Research (California)
Chapter 10 Counseling At Risk Children and Adolescents.
Recovery Support Services and Client Outcomes: What do the Data Tell Us? Recovery Community Services Program Grantee Meeting December 14, 2007.
MIA: STEP Toolkit Overview. NIDA-SAMHSA Blending Initiative 2 What is an MI Assessment?  Use of client-centered MI style  MI strategies that can be.
CARIBBEAN BASIN AND HISPANIC ADDICTION TECHNOLOGY TRANSFER CENTER Effects of a Two-facet Intervention to Reduce HIV Risk Behaviors Among Hispanic Drug.
CPS AND SUBSTANCE ABUSE Milton Ayala, LMSW
Drug Abuse Education Course Master Sgt. Doug Oswald Assistant Drug Demand Reduction Administrator.
A Profile of Women in Treatment in California Data from the California Outcome Measurement System January – December 2006.
Introduction Results and Conclusions On demographic variables, analyses revealed that ATR clients were more likely to be Hispanic and employed, whereas.
Methamphetamine: User Characteristics and Treatment Response Alice Huber, Ph.D. Steven Shoptaw, Ph.D. Richard A. Rawson, Ph.D. Paul Brethen, M.A. Walter.
The Counseling Center, Inc. Devoted to the prevention and treatment of alcoholism and other drug addictions. We promote opportunities for individuals and.
Substance abuse in accordance with academic performance Charlie Berrigan Smiths Falls District Collegiate Institute.
UCLA Integrated Substance Abuse Programs Amity In-Prison Therapeutic Community: Five-Year Outcomes Association of Criminal Justice Research (CA) Sacramento,
Introduction Results and Conclusions Analyses of demographic and social variables revealed that women were more likely to have children, be living in a.
1 Session 3 Treatment and Recovery Treatment and Recovery.
CEACEA CENTROCENTRO DE ESTUDIOS EN ADICCION Testing an Intervention Model to Reduce HIV/AIDS Among Hispanic Drug Users Residing in Puerto Rico Robles RR,
Introduction Results Treatment Needs and Treatment Completion as Predictors of Return-to-Prison Following Community Treatment for Substance-Abusing Female.
Substance Use among Older Adults (Age 50+): Current Prevalence and Future Expectations Presented by Joe Gfroerer U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES.
UCLA Integrated Substance Abuse Programs Richard Rawson, Ph.D. Rachel Gonzales, Ph.D. Funded by: California Alcohol and Drug Programs CalOMS Training for.
Ready (or not) to graduate: Mental and physical health characteristics associated with completing public housing-based, substance abuse treatment in Key.
TREATMENT OF SUBSTANCE USE DISORDERS TX myths 1. Nothing works 2. One approach is superior to all others (“one true light” tradition) 3. All treatment.
Vivia V. McCutcheon, Howard J. Edenburg, John R. Kramer, Kathleen K. Bucholz 9 th Annual Guze Symposium St. Louis, MO February 19, 2009 Gender Differences.
Methamphetamine Use Among Offenders Association for Criminal Justice Research (CA) March 17, 2005 Jerry Cartier / David Farabee / Michael Prendergast University.
What is it? What causes it? What can we do about it?
Kathryn P. Jett Director California Department of Alcohol and Drug Programs.
Substance Abuse Spring Substance-Related Disorders Substance abuse Substance dependence –Tolerance –Withdrawal Substance intoxication 2 Define substance.
Printed by A Follow-Up Study of Patterns of Service Use and Cost of Care for Discharged State Hospital Clients in Community-Based.
Association for Women in Psychology Conference “A Model of Integrated Treatment for Women with Co-Occurring Disorders who are at High Risk for HIV” Presented.
First Steps System of Care Family Systems Collaborations Systems to Systems Nancy Gottlieb, MFT.
Introduction Results and Conclusions Numerous demographic variables were found to be associated with treatment completion. Completers were more likely.
Juvenile Justice In America SOC 106 Part 10: Drug Use and Delinquency.
Recidivism Rates for DCJ Offenders Exiting Residential Treatment June 2007 Kim Pascual Research & Evaluation.
 Reliant on robust monitoring systems  Emphasis changed over time  Limited by data collection systems available  Data collection adapts to allow wider.
Trends in Access to Substance Abuse Treatment for Women and Men: Jeanne C. Marsh, PhD, Hee-Choon Shin, PhD, Dingcai Cao, PhD University of Chicago.
Methadone maintenance in Michigan: Five years of data using a contingency management approach Gary Rhodes, M.A., L.L.P. Golfo Tzilos, M.A. Mark Greenwald,
Hatch-Maillette, M. 1, Calsyn, D. A1,2, Doyle, S. 1, Woods, A
RHAM Student Survey Data Presentation to RHAM Board of Education
State Level Data YRBSS 2005 Youth Drug Use By Gender
State Level Data YRBSS 2003 Youth Drug Use By Gender
State Level Data YRBSS 2003 Youth Drug Use By Gender
Presentation transcript:

Outcomes of Treatment for Methamphetamine Use: LA County (“Treatment-as-Usual”) M.-L. Brecht UCLA Integrated Substance Abuse Programs CATES 3/30/2004

Good News? Bad News? Of every 10 MA users entering treatment, 2 still MA-abstinent 48 mo. after treatment After treatment: 1mo. 12mo. 24mo. 48mo. Still MA-abstinent:

Pattern of Relapse: Graph Shows the Declining % Remaining MA-Abstinent After Treatment (most relapse in first 12 months) (Survival curve=expected % remaining abstinent adjusting for the few (n=30) not yet relapsed but with less than 48 months of follow-up)

This Talk Will Also Describe: Where our data came from Other outcome measures (months with MA use, crime, employment) What’s related to better outcomes

Why Are We Interested in This? Increase in MA prevalence…”epidemic proportions…” and geographic penetration across US Treatment admissions for MA in California have doubled , but total admissions have increased only 17% Little published research on outcomes of treatment for MA use Results may help in designing prevention and intervention strategies

Where Are Our Data From? Random sample of MA admissions (mostly from 1996) From Los Angeles county-funded outpatient and residential programs 76% of sampled clients were located; 75% of those participated in study (n=365) Interviewed in , follow-up in Analysis sample n=350 Data from detailed natural history interview

Who Contributed Data? (n=350) Gender:56% male, 44% female Ethnicity:47% non-Hispanic White 30% Hispanic 17% African-American 6% other Education:32% less than high school 21% high school grad/GED 47% some college/tech/trade school Avg. age at first interview 32.6 years Co-morbidity:19%

Average Age First Use of Substance Alcohol Marijuana Tobacco Inhalants 13yr Downers Hallucinogens PCP Cocaine Tranquilizers Ecstasy Heroin Crack Methamphetamine % have used Over 50% have used Less than 50% have used

Sampled Treatment Episode Age at admission29.4 yr. Residential62% Outpatient 38% Legal pressure51% 1st time in treatment 58% Time in treatment3.7 mo. Completed tx 46%

Other Outcomes: % of Months with MA Use, Crime, Employment Before, During, and After Treatment

What Predicts Better Outcomes? Better outcomes for those –With longer time in treatment (e.g. those with 4 or more mo. of treatment have almost double the rate of 24 and 48 mo. abstinence) –Completing treatment –With more sessions per month of individual counseling and relapse prevention Worse outcomes for those –Whose parents divorced when they were children –Who have sold MA

Most client characteristics considered so far are NOT related, e.g.: Gender, ethnicity, family SES, parent/family drug use Early sexual/physical abuse or arrests, psych comorbidity Age 1 st substance use, age 1 st MA use, injection use, no.drugs used Age at treatment, type of treatment, legal pressure, previous time in treatment

Summary Of every 10 MA users treated, 2 remain MA-abstinent for at least 4 years Most relapse is within first 12 months after treatment Overall 50% reduction in MA use and crime in 2 years after treatment compared to 2 years before treatment; also, increases in employment Better MA-use outcomes related to more time in treatment; few other characteristics related Outcomes for MA treatment look much like outcomes for treatment of other drugs

So……… Treatment for MA use works……. –For some of the people –Some of the time We’re still looking at outcomes for more specific subgroups of MA users (with combinations of characteristics) Challenge—to find out what will improve outcomes

Acknowledgements Funding from NIDA (RO1-DA11020) Project staff: L. Greenwell, A. O’Brien, L. Rodriguez, C. von Mayrhauser, C. Gonzalez, D. Grieshop, M. DelaCruz, A. Hernandez, C. Casey, M. Dylan, P. Sheaff, L. Guzman, R. Lua Cooperating community treatment providers, study participants